Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
Value
Increase
Decrease
Funds Holding
5,684
Funds Holding Change
+32
Funds Holding Growth
+0.6%
Value
$1.49T
Holding in Top 10
909
Top 10 Change
+193
Top 10 Growth
+27%
Value Growth
+7%
New
259
Increased
2,545
Reduced
2,572
Closed
137
Capital Inflow
$54.5B
Capital Outflow
$39.4B
Net Capital Flow
+$15.1B
Capital Flow Change
-$17.9B
Calls
$24.4B
Puts
$21B
Net Calls
+$3.39B
Put/Call Ratio
0.86